Our previous experiments used the hydroxyl metabolism of clozoxazone as a probe of the metabolic activity of CYP2E1, which confirmed that the metabolic activity of CYP2E1 was decreased in BCG-induced hepatitis [3–5], which was the same as the results of this study, and also confirmed the feasibility of this method. This evidence concerns the gene CYP2E1 and Hepatitis.